SEC Form 4Coverage since Jun 1, 2026
$LGND insider trading
Over the last 12 months, Ligand Pharmaceuticals insiders reported no purchases and 13 sales totaling $8.7M across SEC Form 4 filings. 69% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $8.7M 13 events
- Events · 12m
- 13 Form 4 filings, grouped
- Insiders · 12m
- 5 distinct reporters
- 10b5-1 share
- 69% pre-arranged plans
Side
Price · $LGND · 12Mvia TradingView
Top insiders · 12m
Reardon AndrewCLO & Secretary9× · $4.1M
Sabba Stephen L—1× · $545K
LAMATTINA JOHN L—1× · $1.2M
Aryeh Jason—1× · $1.3M
Haas Jason—1× · $1.7M
All insider trades
13 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Reardon AndrewCLO & Secretary · O | ▼ Sale | 5,000 | $288.99 | $1.4M | -10.7% | plan · 10 tranches |
| Jul 1, 2026 | Reardon AndrewCLO & Secretary · O | ▼ Sale | 5,000 | $313.28 | $1.6M | -10.7% | plan · 8 tranches |
| Jun 16, 2026 | Sabba Stephen LD | ▼ Sale | 2,145 | $254 | $545K | -6% | — |
| Jun 12, 2026 | Haas JasonD | ▼ Sale | 6,461 | $255.58 | $1.7M | -56.5% | 2 tranches |
| Jun 11, 2026 | Aryeh JasonD | ▼ Sale | 5,000 | $250 | $1.3M | -4.6% | 2 tranches |
| Jun 10, 2026 | LAMATTINA JOHN LD | ▼ Sale | 4,591 | $250.88 | $1.2M | -14.5% | 4 tranches |
| Jun 1, 2026 | Reardon AndrewCLO & Secretary · O | ▼ Sale | 200 | $230.41 | $46K | -0.5% | plan |
| Jun 1, 2026 | Reardon AndrewCLO & Secretary · O | ▼ Sale | 1,216 | $229.47 | $279K | -2.8% | plan |
| Jun 1, 2026 | Reardon AndrewCLO & Secretary · O | ▼ Sale | 584 | $228.57 | $133K | -1.3% | plan |
| Jun 1, 2026 | Reardon AndrewCLO & Secretary · O | ▼ Sale | 400 | $226.78 | $91K | -0.9% | plan |
| Jun 1, 2026 | Reardon AndrewCLO & Secretary · O | ▼ Sale | 1,432 | $225.97 | $324K | -3.2% | plan |
| Jun 1, 2026 | Reardon AndrewCLO & Secretary · O | ▼ Sale | 677 | $225.2 | $152K | -1.5% | plan |
| Jun 1, 2026 | Reardon AndrewCLO & Secretary · O | ▼ Sale | 491 | $223.95 | $110K | -1.1% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $LGND feed.